# Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer

> **NCT00706615** · PHASE1 · WITHDRAWN · sponsor: **Jonsson Comprehensive Cancer Center**

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** Ad-sig-hMUC-1/ecdCD40L vaccine

## Key facts

- **NCT ID:** NCT00706615
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-07
- **Primary completion:** 2009-04
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no accrual
- **Last updated:** 2020-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00706615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00706615, "Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00706615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*